Spectrum Pharmaceuticals: Raj Sets The Record Straight And Quiets The ... Seeking Alpha He acknowledged that logistical issues and certain requirements for physicians have limited the sales of Zevalin. He compared the drug with the blockbuster lymphoma drug Rituximab, and showed how Zevalin is the better drug, with an 83% overall response ... |
